摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-N-Benzylnormetazocine | 57573-46-3

中文名称
——
中文别名
——
英文名称
(+)-N-Benzylnormetazocine
英文别名
(+)-N-benzyl-N-normetazocine;(2S,6S,11S)-3-Benzyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol;(1S,9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
(+)-N-Benzylnormetazocine化学式
CAS
57573-46-3
化学式
C21H25NO
mdl
——
分子量
307.436
InChiKey
RPMPAQXGZYLEST-NQERJWCQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    23.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (+)-N-Benzylnormetazocine 在 palladium on activated charcoal 盐酸盐酸肼氢气sodium四丁基碘化铵 、 sodium hydride 、 potassium hydrogencarbonate溶剂黄146 作用下, 以 四氢呋喃吡啶甲醇乙醇N,N-二甲基甲酰胺异丙醇 为溶剂, 反应 60.5h, 生成 (+)-2'-amino-2-benzyl-5,9α-dimethyl-6,7-benzomorphan
    参考文献:
    名称:
    Synthesis and .sigma. Binding Properties of 2'-Substituted 5,9.alpha.-Dimethyl-6,7-benzomorphans
    摘要:
    The synthesis and sigma 1 and sigma 2 binding properties of several (+)- and (-)-2-benzyl- and 2-dimethylallyl-2'-substituted-5,9 alpha-dimethyl-6,7-benzomorphans (3 and 4) are presented. In agreement with previously reported binding data for 2-substituted 5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans (N-substituted-N-normetazocine), all (1S,5S,SS)-(+)-isomers showed higher affinity for the sigma 1 site than the corresponding (1R,5R,9R)-(-)-isomers. Replacement of the 2'-hydroxy group of (+)-2-benzyl-5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan [(+)-1f] with a 2'-NH2 and 2'-N(CH3)(2) [(+)-3b and (+)-3c, respectively] had only a small effect on the sigma 1 K-i values. Changing the 2'-hydroxy group of (+)-1f to an H, F, Cl, Br, I, NHAc, or NHSO2CH3 resulted in a 5-fold or greater loss in potency. In contrast, replacement of the 2'-hydroxy group of (+)-2-(dimethylallyl)-5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan [(+)-1b, (+)-pentazocine] with a 2'-H or 2'-F group resulted in a 2-fold increase in potency. Conversion of (+)-1f to its 2'-desoxy analogue (+)-2d resulted in a 27.5-fold loss in affinity. This suggests that (+)-1f and other N-substituted benzomorphan analogues may be binding to single al receptors in a different way or to different sigma 1 receptors. (-)-Pentazocine [(-)-1b] and its 2'-fluoro analogue, (-)-2-(dimethylallyl)-5,9 alpha-dimethyl-2'-fluoro-6,7-benzomorphan [(-)-4a] showed the highest potency for the sigma 2 binding site.
    DOI:
    10.1021/jm00015a022
  • 作为产物:
    描述:
    (2alpha,6alpha,11R*)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 、 alkaline earth salt of/the/ methylsulfuric acid 在 碳酸氢钠 作用下, 以 乙醇 为溶剂, 反应 5.0h, 以67%的产率得到(+)-N-Benzylnormetazocine
    参考文献:
    名称:
    对映体N-取代的N-去甲偶氮胺:对sigma,PCP和mu阿片受体的亲和力的比较研究。
    摘要:
    N-烯丙基-N-去甲甲氮嗪的光学对映体(2; SKF 10047,NANM)是用于σ受体分类的原始化合物,与其他受体(例如PCP(NMDA),阿片类和多巴胺受体)不同。后来的研究表明(+)-N-(二甲基烯丙基)-N-去甲偶氮辛[(+)-4,(+)-戊三嗪]对sigma受体更有效且更具选择性。为了获得更多的结构-活性关系信息,制备了几种N-取代的N-正甲氮嗪类似物,并对其σ-1([3H]-(+)-3-PPP或[3H]-(+)-戊唑嗪进行了评估),PCP([3H] TCP)和mu阿片类药物([3H] DAMGO)受体结合亲和力。(+)-N-苄基-N-去甲偶氮辛[(+)-10)对sigma位点具有亚纳摩尔亲和力,Ki = 0.67。类似物(+)-10的选择性分别超过14,000和2400倍,相对于PCP和mu阿片类药物受体来说是σ受体。N-取代的N-去甲氮嗪对sigma位点是对映选择性的。(+)
    DOI:
    10.1021/jm00093a014
点击查看最新优质反应信息

文献信息

  • Synthesis and .sigma. Binding Properties of 2'-Substituted 5,9.alpha.-Dimethyl-6,7-benzomorphans
    作者:Richmond Danso-Danquah、Xu Bai、X. Zhang、S. Wayne Mascarella、Wanda Williams、Bethel Sine、Wayne D. Bowen、F. Ivy Carroll
    DOI:10.1021/jm00015a022
    日期:1995.7
    The synthesis and sigma 1 and sigma 2 binding properties of several (+)- and (-)-2-benzyl- and 2-dimethylallyl-2'-substituted-5,9 alpha-dimethyl-6,7-benzomorphans (3 and 4) are presented. In agreement with previously reported binding data for 2-substituted 5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans (N-substituted-N-normetazocine), all (1S,5S,SS)-(+)-isomers showed higher affinity for the sigma 1 site than the corresponding (1R,5R,9R)-(-)-isomers. Replacement of the 2'-hydroxy group of (+)-2-benzyl-5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan [(+)-1f] with a 2'-NH2 and 2'-N(CH3)(2) [(+)-3b and (+)-3c, respectively] had only a small effect on the sigma 1 K-i values. Changing the 2'-hydroxy group of (+)-1f to an H, F, Cl, Br, I, NHAc, or NHSO2CH3 resulted in a 5-fold or greater loss in potency. In contrast, replacement of the 2'-hydroxy group of (+)-2-(dimethylallyl)-5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphan [(+)-1b, (+)-pentazocine] with a 2'-H or 2'-F group resulted in a 2-fold increase in potency. Conversion of (+)-1f to its 2'-desoxy analogue (+)-2d resulted in a 27.5-fold loss in affinity. This suggests that (+)-1f and other N-substituted benzomorphan analogues may be binding to single al receptors in a different way or to different sigma 1 receptors. (-)-Pentazocine [(-)-1b] and its 2'-fluoro analogue, (-)-2-(dimethylallyl)-5,9 alpha-dimethyl-2'-fluoro-6,7-benzomorphan [(-)-4a] showed the highest potency for the sigma 2 binding site.
  • Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at .sigma., PCP, and .mu. opioid receptors
    作者:F. I. Carroll、P. Abraham、K. Parham、X. Bai、X. Zhang、G. A. Brine、S. W. Mascarella、B. R. Martin、E. L. May、C Sauss、L Di Paolo、P Wallace、J. M. Walker、W. D. Bowen
    DOI:10.1021/jm00093a014
    日期:1992.7
    their sigma-1 ([3H]-(+)-3-PPP or [3H]-(+)-pentazocine), PCP ([3H]TCP), and mu opioid ([3H]DAMGO) receptor binding affinities. (+)-N-Benzyl-N-normetazocine [(+)-10)] possessed subnanomolar affinities for the sigma site, Ki = 0.67. The analog (+)-10 showed greater than 14,000- and 2400-fold selectivity, respectively, for the sigma receptor relative to the PCP and mu opioid receptors. The N-substituted
    N-烯丙基-N-去甲甲氮嗪的光学对映体(2; SKF 10047,NANM)是用于σ受体分类的原始化合物,与其他受体(例如PCP(NMDA),阿片类和多巴胺受体)不同。后来的研究表明(+)-N-(二甲基烯丙基)-N-去甲偶氮辛[(+)-4,(+)-戊三嗪]对sigma受体更有效且更具选择性。为了获得更多的结构-活性关系信息,制备了几种N-取代的N-正甲氮嗪类似物,并对其σ-1([3H]-(+)-3-PPP或[3H]-(+)-戊唑嗪进行了评估),PCP([3H] TCP)和mu阿片类药物([3H] DAMGO)受体结合亲和力。(+)-N-苄基-N-去甲偶氮辛[(+)-10)对sigma位点具有亚纳摩尔亲和力,Ki = 0.67。类似物(+)-10的选择性分别超过14,000和2400倍,相对于PCP和mu阿片类药物受体来说是σ受体。N-取代的N-去甲氮嗪对sigma位点是对映选择性的。(+)
查看更多

同类化合物

非那佐辛 酮佐辛盐酸盐 酮佐辛 莫克索兴 苄卡镇痛新 脱氧-N-苄基去甲美他佐辛 美他佐辛 环佐辛 环丙止痛胺 格各佐辛 布马佐辛 化合物 T27086 乳酸,化合物与(2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-六氢-6,11-二甲基-3-(3-甲基丁-2-烯基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇(1:1) N-(3-氟丙基)-N-去甲美他唑新 6-乙氧基-2,2,4-三甲基-1,2-二氢喹啉 6,11-二甲基-3-丙基-1,2,3,4,5,6-六氢-2,6-亚甲基-3-苯并吖辛因 5-乙基-2'-羟基-2(N)-(3-甲基-2-丁烯基)-9-甲基-6,7-苯并吗吩烷 3-苄基-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-己基-6,11-二甲基-1,2,3,4,5,6-六氢-2,6-亚甲基-3-苯并吖辛因 3-(环戊基甲基)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-(环丙基羰基)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-(环丁基甲基)-6,11-二甲基-1,2,3,4,5,6-六氢-8-甲氧基-2,6-甲桥-3-苯并氮杂环辛四烯 2-羟基-丙酸3-(环丁基甲基)-6-乙基-1,2,3,4,5,6-六氢-11,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-基酯 2-丙烯酸,2-甲基-,聚合丁基2-丙烯酸酯,乙烯基苯,2-羟基乙基2-丙烯酸酯,甲基2-甲基-2-丙烯酸酯和噁丙环基甲基2-甲基-2-丙烯酸酯 10-(环丙基甲基)-1,13-二甲基-10-氮杂三环[7.3.1.02,7]十三-2,4,6-三烯-4-醇 1,2,3,4,5,6-六氢-6-乙基-3-甲基-(+-)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-6,11-二甲基-3-(3-甲基丁-2-烯基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇盐酸盐 1,2,3,4,5,6-六氢-6,11-二甲基-3-(2-丙炔基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-环丁基甲基-6-乙基-1-甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(环丙基甲基)-6,11-二甲基-8-甲氧基-2,6-甲桥-3-苯并氮杂环辛四烯 1,2,3,4,5,6-六氢-3-(氰基甲基)-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(3,3-二氯-2-丙烯基)-6-乙基-11-甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(3,3-二氯-2-丙烯基)-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 (2alpha,6alpha,11R*)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 (2S-(2a,6a,11R)-1,2,3,4,5,6-六氢-6,11-二甲基-3-(2-丙烯基)-2,6-亚甲基-3-苯并吗吩烷-8-醇盐酸盐 (-)-布马佐辛盐酸盐 (-)-去甲美他佐辛 (-)-N-丙烯基去甲变肾上腺素 盐酸盐 (-)-5,9alpha-二乙基-2'-羟基苯并吗吩烷 (+-)-(2alpha,6alpha,11R*)-苯硫代羧酸S-(1,2,3,4,5,6-六氢-3,6,11-三甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-基)酯(E)-2-丁烯二酸盐(1:1)水合物 (+)-环佐辛 (+)-喷他佐辛 (+/-)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-2,6-methano-3-benzazocin-8-thiocarboxamide 8-carboxamidocyclazocine (+/-)-3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-N-(4-dimethylaminophenyl)-2,6-methano-3-benzazocin-8-amine (+)-pentazocine 5,9-dimethyl-2'-hydroxy-6,7-benzomorphan (-)-cis-2-(3,3-dimethylallyl)-5,9α-dimethyl-2'-fluoro-6,7-benzomorphan (+)-cis-2-(3,3-dimethylallyl)-5,9α-dimethyl-2'-fluoro-6,7-benzomorphan (-)-2'-fluoro-5,9α-dimethyl-6,7-benzomorphan